Discover verified cancer discoveries

Search and filter stories that passed editorial review. Evidence strength, regulatory status, and guideline position are shown separately and are never inferred from one another.

Filter discoveries

Results

Active filters:

Cancer type: Bladder Cancer Remove Cancer type filter
Regulatory status: FDA-approved for the exact stated cancer/use Remove Regulatory status filter

Clear all

1 verified discovery matches your filters.

FDA approves the first ctDNA-guided adjuvant immunotherapy, for bladder cancer after surgery

Later-Stage HumanFDA Approved

Cancer type: Bladder Cancer
Published: August 13, 2026

In the randomized, phase 3 IMvigor011 trial, atezolizumab reduced the risk of disease recurrence or death by 36% and the risk of death by 41% compared with placebo, specifically in…

Primary source cited

Last reviewed 2026-08-13